Solvent subset selection for polymorph screening

被引:12
作者
Alleso, Morten [1 ]
Rantanen, Jukka [1 ]
Aaltonen, Jaakko [2 ]
Cornett, Claus [1 ]
van den Berg, Frans [3 ]
机构
[1] Univ Copenhagen, Fac Pharmaceut Sci, Dept Pharmaceut & Analyt Chem, Copenhagen, Denmark
[2] Univ Helsinki, Fac Pharm, Div Pharmaceut Technol, Helsinki, Finland
[3] Univ Copenhagen, Fac Life Sci, Dept Food Sci, Frederiksberg C, Denmark
关键词
solvent selection; Federov D-optimal; Kennard-Stone; principal properties; cluster analysis;
D O I
10.1002/cem.1107
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
In polymorph screening it is imperative to maximize the physicochemical diversity of solvents used in crystallization experiments. This is done in order to increase the probability of finding as many crystal forms of the compound as possible. When setting up a complete solid form screening scheme it is common practice to work with solvent subsets of varying sizes, adequately spanning the chemical space. There exists a wide array of algorithms to perform this pre-experimental selection. Prior to the implementation of these methods, the impact on the physicochemical diversity observed in the selected subsets should be fully understood. In the current study subsets of 5, 10 and 20 solvents were selected from a database of 218 organic solvents times 24 property descriptors. For this purpose four mathematically different subset selection algorithms were tested and compared: Federov D-optimal selection, Kennard-Stone selection, Principal Properties selection and a Cluster-Based selection. Federov D-optimal, Kennard-Stone and the Cluster-Based selection primarily sampled in the outer regions of solvent space, whereas the Principal Properties approach represented more of a compromising solution selecting solvents closer to the centre. In conclusion, subset selection algorithms in crystallization experimental design should be used to guarantee physicochemical diversity, though it is recommended that the computed selection is supplemented with solvents selected based on chemical knowledge of the particular compound being screened. Copyright (C) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:621 / 631
页数:11
相关论文
共 17 条
[1]   Polymorph screening using near-infrared spectroscopy [J].
Aaltonen, J ;
Rantanen, J ;
Siiriä, S ;
Karjalainen, M ;
Jorgensen, A ;
Laitinen, N ;
Savolainen, M ;
Seitavuopio, P ;
Louhi-Kultanen, M ;
Yliruusi, J .
ANALYTICAL CHEMISTRY, 2003, 75 (19) :5267-5273
[2]   Solvent diversity in polymorph screening [J].
Alleso, Morten ;
Van Den Berg, Frans ;
Cornett, Claus ;
Jorgensen, Flemming Steen ;
Halling-Sorensen, Bent ;
De Diego, Heidi Lopez ;
Hovgaard, Lars ;
Aaltonen, Jaakko ;
Rantanen, Jukka .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (06) :2145-2159
[3]   Strategies for subset selection of parts of an in-house chemical library [J].
Andersson, PM ;
Sjöström, M ;
Wold, S ;
Lundstedt, T .
JOURNAL OF CHEMOMETRICS, 2001, 15 (04) :353-369
[4]  
[Anonymous], POLYMORP PHARM IND, DOI [10.1002/3527607889.ch11, DOI 10.1002/3527607889.CH11]
[5]   SCREENING OF SUITABLE SOLVENTS IN ORGANIC-SYNTHESIS - STRATEGIES FOR SOLVENT SELECTION [J].
CARLSON, R ;
LUNDSTEDT, T ;
ALBANO, C .
ACTA CHEMICA SCANDINAVICA SERIES B-ORGANIC CHEMISTRY AND BIOCHEMISTRY, 1985, 39 (02) :79-91
[6]   A novel approach for screening discrete variations in organic synthesis [J].
Carlson, R ;
Carlson, J ;
Grennberg, A .
JOURNAL OF CHEMOMETRICS, 2001, 15 (05) :455-474
[7]   Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development [J].
Chemburkar, SR ;
Bauer, J ;
Deming, K ;
Spiwek, H ;
Patel, K ;
Morris, J ;
Henry, R ;
Spanton, S ;
Dziki, W ;
Porter, W ;
Quick, J ;
Bauer, P ;
Donaubauer, J ;
Narayanan, BA ;
Soldani, M ;
Riley, D ;
McFarland, K .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2000, 4 (05) :413-417
[8]   Constructing D-optimal designs from a list of candidate samples [J].
Ferre, J ;
Rius, FX .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 1997, 16 (02) :70-73
[9]   An automated parallel crystallisation search for predicted crystal structures and packing motifs of carbamazepine [J].
Florence, Alastair J. ;
Johnston, Andrea ;
Price, Sarah L. ;
Nowell, Harriott ;
Kennedy, Alan R. ;
Shankland, Norman .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (09) :1918-1930
[10]  
Guillory JK, 1999, DRUGS PHARM SCI, V95, P183